Rocket Pharmaceuticals (RCKT) Other financing activities (2015 - 2024)
Rocket Pharmaceuticals (RCKT) posted Other financing activities of $321000.0 for Q4 2024, up 82.39% sequentially from $176000.0 in Q3 2024, and down 85.57% YoY from $2.2 million in Q1 2024.
Rocket Pharmaceuticals (RCKT) Other financing activities (2015 - 2024) Analysis & Trends
Rocket Pharmaceuticals has reported Other financing activities for 8 years, with the latest figure at $321000.0 in Q4 2024.
- Quarterly Other financing activities fell 85.57% year-over-year to $321000.0 in Q4 2024, while the trailing twelve-month figure through Sep 2025 was $321000.0 (down 93.72% YoY) and the FY2024 annual result came in at $3.2 million, up 43.93% from the prior year.
- Other financing activities advanced to $321000.0 in Q4 2024 per RCKT's latest filing, from $176000.0 in the prior quarter.
- Over five years, Other financing activities peaked at $280.8 million in Q4 2020 and troughed at -$10.2 million in Q4 2021.
- A 5-year average of $19.1 million and a median of $631000.0 in 2022 frame the typical range for Other financing activities.
- The widest YoY moves for Other financing activities: up 37066.67% in 2021, down 103.63% in 2021.
- Over 5 years, Other financing activities stood at $280.8 million in 2020, then plunged by 103.63% to -$10.2 million in 2021, then soared by 106.19% to $631000.0 in 2022, then soared by 252.46% to $2.2 million in 2023, then sank by 85.57% to $321000.0 in 2024.
- According to Business Quant data, Other financing activities over the past three periods registered $321000.0, $176000.0, and $1.5 million for Q4 2024, Q3 2024, and Q2 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Rocket Pharmaceuticals | 380.92 Mn | 380.92 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 321,000.00 |
| Dec 31, 2024 | 321,000.00 |
| Sep 30, 2024 | 176,000.00 |
| Sep 30, 2024 | 176,000.00 |
| Jun 30, 2024 | 1.53 Mn |
| Jun 30, 2024 | 1.53 Mn |
| Mar 31, 2024 | 1.18 Mn |
| Mar 31, 2024 | 1.18 Mn |
| Dec 31, 2023 | 2.22 Mn |
| Dec 31, 2023 | 2.22 Mn |
| Jun 30, 2023 | -1.11 Mn |
| Jun 30, 2023 | -1.11 Mn |
| Mar 31, 2023 | 1.11 Mn |
| Mar 31, 2023 | 1.11 Mn |
| Dec 31, 2022 | 631,000.00 |
| Dec 31, 2022 | 631,000.00 |
| Dec 31, 2021 | -10.19 Mn |
| Dec 31, 2021 | -10.19 Mn |
| Sep 30, 2021 | 284,000.00 |
| Sep 30, 2021 | 284,000.00 |